Efficacy and Safety of Specific Immunotherapy With CLUSTOID Grass Pollen

Launched by ROXALL MEDIZIN · Nov 12, 2009

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Positive history of allergic rhinitis/rhinoconjunctivitis due to grass and/or rye pollen
• • Positive screening skin prick test (wheal diameter \> 3 mm)
• • Compliance and ability of the patient to complete a Diary Card for self-evaluating of the symptoms and antisymptomatic medication
• • Signed and dated patient´s Informed Consent,
• Exclusion Criteria:
• • Previous immunotherapy with grass and/or rye pollen extracts within the last 3 years,
• • Simultaneous participation in other clinical trials,
• • Other reasons contra-indicating an inclusion into the trial according to the investigator´s estimation (e.g. poor compliance),
• • Auto-immune disorders,
• • Severe chronic inflammatory diseases,
• • Malignancy,
• • Alcohol abuse,
• • Existing or intended pregnancy, lactation and/or lack of adequate contraceptive protection,
• • Patients being in any relationship or dependency with the sponsor and/or investigator,
• • Treatment with beta-blockers (incl. local application) and/or other contra-indicated drugs.